» Articles » PMID: 10784608

Antigen-specific Cellular Hyporesponsiveness in a Chronic Human Helminth Infection is Mediated by T(h)3/T(r)1-type Cytokines IL-10 and Transforming Growth Factor-beta but Not by a T(h)1 to T(h)2 Shift

Overview
Journal Int Immunol
Date 2000 Apr 28
PMID 10784608
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure to infective larvae of the filarial nematode Onchocerca volvulus (Ov) either results in patent infection (microfilaridermia) or it leads to a status called putative immunity, characterized by resistance to infection. Similar to other chronic helminth infections, there is a T cell proliferative hyporesponsiveness to Ov antigen (OvAg) by peripheral blood mononuclear cells (PBMC) from individuals with patent infection, i.e. generalized onchocerciasis (GEO), compared to PBMC from putatively immune (PI) individuals. In this study, mechanisms mediating this cellular hyporesponsiveness in GEO were investigated: the low proliferative response in PBMC from GEO individuals was associated with a lack of IL-4 production and significantly lower production of IL-5 compared to those from PI individuals, arguing against a general shift towards a T(h)2 response being the cause of hyporesponsiveness. In contrast, IL-10 and transforming growth factor (TGF)-beta, two cytokines associated with a T(h)3 response, seemed to mediate hyporesponsiveness: PBMC from individuals with GEO produced significantly more IL-10, and T cell proliferative hyporesponsiveness in this group could be reversed by the addition of anti-IL-10 and anti-TGF-beta antibodies. Hyporesponsiveness was specific for OvAg and not observed upon stimulation with related nematode antigens, arguing for a T cell-mediated, Ov-specific down-regulation. Ov-specific T cells could be cloned from GEO PBMC which have a unique cytokine profile (no IL-2 but high IL-10 and/or TGF-beta production), similar to the T cell subsets known to suppress ongoing inflammation (T(h)3 and T(r)1), indicating that this cell type which has not been found so far in infectious diseases may be involved in maintaining Ov-specific hyporesponsiveness.

Citing Articles

Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials.

Nebangwa D, Shey R, Shadrack D, Shintouo C, Yaah N, Yengo B PLoS One. 2024; 19(10):e0312315.

PMID: 39432476 PMC: 11493244. DOI: 10.1371/journal.pone.0312315.


Filariasis research - from basic research to drug development and novel diagnostics, over a decade of research at the Institute for Medical Microbiology, Immunology and Parasitology, Bonn, Germany.

Karunakaran I, Ritter M, Pfarr K, Klarmann-Schulz U, Debrah A, Debrah L Front Trop Dis. 2024; 4.

PMID: 38655130 PMC: 7615856. DOI: 10.3389/fitd.2023.1126173.


Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways.

Chu Y, Liao M, Tsai K, Lu K, Hu W Biomedicines. 2023; 11(9).

PMID: 37760825 PMC: 10525553. DOI: 10.3390/biomedicines11092384.


Epilepsy and nodding syndrome in association with an Onchocerca volvulus infection drive distinct immune profile patterns.

Arndts K, Kegele J, Massarani A, Ritter M, Wagner T, Pfarr K PLoS Negl Trop Dis. 2023; 17(8):e0011503.

PMID: 37535695 PMC: 10426931. DOI: 10.1371/journal.pntd.0011503.


Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease.

Front Immunol. 2023; 13:1125497.

PMID: 36761160 PMC: 9903213. DOI: 10.3389/fimmu.2022.1125497.